Accessibility Tools

What is Skin Cancer Evaluation and Diagnosis?

Skin cancer evaluation and diagnosis is the process of examining the skin to detect, identify, and confirm the presence of skin cancer. It involves a detailed clinical assessment and, if necessary, laboratory or imaging tests to determine the type and stage of the cancer.

What is Skin Cancer?

Skin cancer is the abnormal and uncontrolled growth of skin cells, most often caused by damage from ultraviolet (UV) radiation from the sun or tanning beds. It occurs when the DNA in skin cells becomes damaged, leading to mutations that cause cells to grow and divide uncontrollably.

There are three main types of skin cancer:

  • Basal Cell Carcinoma (BCC): The most common and least aggressive type, often appearing as a pearly bump or pink patch, usually on sun-exposed areas.
  • Squamous Cell Carcinoma (SCC): May appear as a scaly, red patch or sore that does not heal. It can spread if not treated promptly.
  • Melanoma: The most serious form, developing from pigment-producing cells (melanocytes). It often appears as a new or changing mole with irregular borders or multiple colours.

Skin cancer can usually be successfully treated when detected early, making regular skin checks and early evaluation crucial for prevention and good outcomes.

When is Skin Cancer Evaluation and Diagnosis Recommended?

Skin cancer evaluation and diagnosis are recommended when there are suspicious changes in the skin that may indicate cancer. This includes noticing a new growth, mole, or spot that changes in size, shape, or colour, bleeds easily, does not heal, or causes itching or pain. It is also advised for individuals with a history of excessive sun exposure, use of tanning beds, fair skin, or a family or personal history of skin cancer. Routine skin evaluations are particularly important for those at high risk, as early detection greatly improves treatment success and outcomes.

What Does Skin Cancer Evaluation and Diagnosis Involve?

The process of skin cancer evaluation and diagnosis typically begins with a comprehensive skin examination, during which a dermatologist inspects the skin for suspicious moles, growths, or lesions using a dermatoscope - a handheld magnifying device that enhances surface and subsurface features of the skin.

If a suspicious lesion is found, the next step is usually a skin biopsy, where a small tissue sample is taken for microscopic analysis by a pathologist. Different biopsy techniques include shave biopsy, punch biopsy, and excisional biopsy, depending on the lesion’s size, location, and suspected type.

Once the tissue sample is examined, a definitive diagnosis is made, identifying whether the lesion is benign, precancerous, or malignant (such as basal cell carcinoma, squamous cell carcinoma, or melanoma). Additional imaging tests, such as lymph node ultrasound, CT, or PET scans, may be used if there is suspicion of metastasis or deeper invasion.

These modalities together ensure early detection, accurate diagnosis, and appropriate staging of skin cancer. Early and accurate diagnosis is crucial, as it allows timely intervention, reducing the risk of spread and improving overall treatment outcomes.